Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Respiratory-Gated Vagal Nerve Stimulation for Chronic Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04053127
Recruitment Status : Recruiting
First Posted : August 12, 2019
Last Update Posted : August 12, 2019
Sponsor:
Information provided by (Responsible Party):
Robert Edwards, Brigham and Women's Hospital

Brief Summary:

Vagus Nerve Stimulation (VNS) is a validated and FDA-approved therapy that has improved the lives of many individuals with epilepsy and depression and has shown promise for treating chronic pain. However, there is moderate morbidity associated with the surgical procedure and maintenance of VNS. The study team has developed a novel, non-invasive procedure based on the neurobiology of VNS treatment which is termed Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS). The investigators hope to maximize efficacy and better understand applicability of RAVANS by applying this to chronic pain patients with a range of psychiatric and psychological comorbidity. This high-distress subpopulation of chronic pain patients has been notoriously difficult to treat and is in need of new, innovative therapies. The investigators propose applying electrical stimulation of the somatosensory vagal afferent receptors in the ear using transcutaneous-VNS (t-VNS) during the exhalation phase of breathing in order to augment the clinical efficacy of t-VNS.

This proposal includes a single blinded, controlled design for testing the impact of RAVANS therapy on pain and mood fro chronic pain. Patients will complete 2 in-person visits, one with RAVANS therapy and one with non-RAVANS stimulation. During each session, participants will complete questionnaires, quantitative sensory testing (QST), and receive either real or sham RAVANS stimulation.


Condition or disease Intervention/treatment Phase
Chronic Pain Device: RAVANS Not Applicable

Detailed Description:

Testing will occur over the course of 2 2-3 hour study visits. After completing consent forms, participants will complete questionnaires and undergo baseline Quantitative Sensory Testing (QST). After baseline sensory testing and completion of measures, participants will complete a 30-minute rest period during which time they are instructed to relax and regulate their breathing. After the rest, they will receive a 30-minute RAVANS or non-RAVANS stimulation. Following the RAVANS stimulation, participants will again undergo QST testing. Throughout the session, subjects will rate pain and mood using numeric rating scales and physiological monitoring will occur as described below.

RAVANS stimulation Electrodes will be placed in the auricle of the left ear. Electrical stimulation to these electrodes will be provided by a current-constant stimulator (Urostim, Schwa-Medico). Stimulation will be gated, with 1-second delay, after peak inhalation (i.e. during exhalation). Respiratory gating for stimulation will require real-time evaluation of the respiratory cycle. The study will use a belt system constructed in-house, and similar to the system used in several previous studies. A pneumatic belt will be placed around the subject's lower thorax. Once electrodes are set up, subjects will be asked to rate stimulation intensity on a NRS of 0 to 10 (0: no sensation, 10: pain detection threshold). Current intensity will be set to achieve moderate to strong (but not painful) sensation, and this current intensity will be used on subsequent stimulation runs.

Non-RAVANS stimulation For sessions randomized to sham stimulation, the electrodes in the ear will remain as described above, but the leads will be disconnected from the stimulator. Subjects will be instructed that for this session they may or may not feel pulsing in their ear, and that the goal is to ensure that the stimulus was not painful.

Physiological Monitoring In addition to respiration, which by necessity will be monitored with the pneumatic belt as part of the RAVANS procedure, the investigators will also collect ECG data. The ECG signal will also be acquired by a laptop device system, temporally locked to the respiratory signal. The ECG can be used to quantify heart rate and heart rate variability.

Sensory Tests to be Completed at Baseline and After Experimental Condition:

These procedures are similar to those used in ongoing QST studies (e.g., IRB protocols 2009P001020, 2010P000978, 2015P002373).

Mechanical pain: Responses to punctate mechanical stimuli will be measured using a standard set of weighted probes that provide estimates of pain threshold and mechanical temporal summation. Series of 10 stimuli (with 1-second inter-stimulus intervals) will be used to assess the temporal summation of pain that occurs with rapid administration of identical stimuli. A Somedic pressure algometer will be utilized to assess responses to pressure stimulation at several anatomical sites. Pain pressure thresholds (PPT) will be determined twice at the knee, trapezius, and thumb. Mechanical pressure will be applied using a 0.5-cm2 probe covered with 1mm polypropylene pressure-transducing material; pressure is increased at a steady rate of 30 kPA/s until the subject indicates that the pressure has become painful. Finally, the study will use cuff algometry to assess responses to sustained mechanical pressure. A Hokanson rapid cuff inflator will be used to inflate a standard blood pressure cuff around the gastrocnemius muscle to a moderately painful level for up to 2 minutes. Participants will indicate when the pressure first becomes painful (i.e., pain threshold) and will provide pain ratings every 30 seconds. As with each of these psychophysical testing procedures, participants are informed that they may terminate the procedure at any time.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Respiratory-Gated Vagal Nerve Stimulation for Chronic Pain
Actual Study Start Date : November 1, 2018
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Chronic Pain

Arm Intervention/treatment
Experimental: RAVANS
Electrodes will be placed in the auricle of the left ear. Electrical stimulation to these electrodes will be provided by a current-constant stimulator (Urostim, Schwa-Medico). Stimulation will be gated, with 1-second delay, after peak inhalation (i.e. during exhalation). Respiratory gating for stimulation will require real-time evaluation of the respiratory cycle. The study will use a belt system constructed in-house, and similar to the system used in several previous studies. A pneumatic belt will be placed around the subject's lower thorax. Once electrodes are set up, subjects will be asked to rate stimulation intensity on a NRS of 0 to 10 (0: no sensation, 10: pain detection threshold). Current intensity will be set to achieve moderate to strong (but not painful) sensation, and this current intensity will be used on subsequent stimulation runs.
Device: RAVANS
Electrical stimulation of somatosensory vagal afferent receptors in the ear modulated by respiration.
Other Name: Respiratory-gated Auricular Vagal Afferent Nerve Stimulation

Sham Comparator: non-RAVANS
For sessions randomized to sham stimulation, the electrodes in the ear will remain as described above, but the leads will be disconnected from the stimulator. Subjects will be instructed that for this session they may or may not feel pulsing in their ear, and that the goal is to ensure that the stimulus was not painful.
Device: RAVANS
Electrical stimulation of somatosensory vagal afferent receptors in the ear modulated by respiration.
Other Name: Respiratory-gated Auricular Vagal Afferent Nerve Stimulation




Primary Outcome Measures :
  1. Mechanical Temporal Summation [ Time Frame: immediately post-RAVANS stimulation ]
    Increases in pain with repeated mechanical stimulation

  2. Pressure Pain Sensitivity [ Time Frame: immediately post-RAVANS stimulation ]
    Thresholds for pressure pain assessed at several body sites


Secondary Outcome Measures :
  1. Pain Severity [ Time Frame: immediately post-RAVANS ]
    Brief Pain Inventory



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. age 21-65.
  2. chronic pain lasting for more than 6 months as the primary complaint.
  3. typical pain ratings ≥ 3/10 on a visual analogue scale.
  4. able to speak and understand English.

Exclusion Criteria:

  1. evidence of delirium, dementia, psychosis, or other cognitive impairment preventing completion of study procedures.
  2. history of cardiac or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome.
  3. current peripheral neuropathy.
  4. current pregnancy, or intention to become pregnant during the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04053127


Contacts
Layout table for location contacts
Contact: Robert R Edwards, PhD 617-732-9486 rredwards@bwh.harvard.edu

Locations
Layout table for location information
United States, Massachusetts
Robert Edwards Recruiting
Chestnut Hill, Massachusetts, United States, 02467
Contact: Robert Edwards    617-732-9486    rredwards@partners.org   
Sponsors and Collaborators
Brigham and Women's Hospital
Investigators
Layout table for investigator information
Principal Investigator: Vitaly Napadow, Ph.D. MGH & BWH

Layout table for additonal information
Responsible Party: Robert Edwards, Clinical Psychologist, Brigham and Women's Hospital
ClinicalTrials.gov Identifier: NCT04053127     History of Changes
Other Study ID Numbers: RAVANS_PILOT
First Posted: August 12, 2019    Key Record Dates
Last Update Posted: August 12, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: No individual data will be shared.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by Robert Edwards, Brigham and Women's Hospital:
vagus nerve stimulation
Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Pain
Pain
Neurologic Manifestations
Signs and Symptoms